Patents by Inventor Myra L. Patchen

Myra L. Patchen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage unit comprising a prostaglandin analog for treating constipation
    Patent number: 8389542
    Abstract: A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: March 5, 2013
    Assignee: Sucampo AG
    Inventors: Ryuji Ueno, Myra L. Patchen
  • DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION
    Publication number: 20120088824
    Abstract: A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 12, 2012
    Applicant: SUCAMPO AG
    Inventors: Ryuji UENO, Myra L. PATCHEN
  • Dosage unit comprising a prostaglandin analog for treating constipation
    Patent number: 8097653
    Abstract: A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
    Type: Grant
    Filed: November 14, 2002
    Date of Patent: January 17, 2012
    Assignee: Sucampo AG
    Inventors: Ryuji Ueno, Myra L. Patchen
  • Very high molecular weight ?-glucans
    Patent number: 7566704
    Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble ?-glucan composition comprising ?-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: July 28, 2009
    Assignee: Biopolymer Engineering, Inc.
    Inventors: Myra L. Patchen, Spiros Jamas, D. Davidson Easson, Jr., Gary R. Ostroff
  • Very high molecular weight ?-glucans
    Patent number: 7022685
    Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble ?-glucan composition comprising ?-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: April 4, 2006
    Assignee: Biopolymer Engineering, Inc.
    Inventors: Myra L. Patchen, Spiros Jamas, D. Davidson Easson, Jr., Gary R. Ostroff
  • Dosage unit comprising a prostaglandin analog for treating constipation
    Publication number: 20030119898
    Abstract: A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
    Type: Application
    Filed: November 14, 2002
    Publication date: June 26, 2003
    Applicant: SUCAMPO, A.G.
    Inventors: Ryuji Ueno, Myra L. Patchen
  • Very high molecular weight beta-glucans
    Publication number: 20020143174
    Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble &bgr;-glucan composition comprising &bgr;-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
    Type: Application
    Filed: March 7, 2002
    Publication date: October 3, 2002
    Applicant: Biopolymer Engineering, Inc.
    Inventors: Myra L. Patchen, Spiros Jamas, D. Davidson Easson, Gary R. Ostroff
  • Very high molecular weight &bgr;-glucans
    Patent number: 6369216
    Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble &bgr;-glucan composition comprising &bgr;-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
    Type: Grant
    Filed: June 3, 1999
    Date of Patent: April 9, 2002
    Assignee: Biopolymer Engineering Pharmaceutical, Inc.
    Inventors: Myra L. Patchen, Spiros Jamas, D. Davidson Easson, Jr., Gary R. Ostroff
  • Mobilization of peripheral blood precursor cells by .beta.(1,3)-glucan
    Patent number: 6117850
    Abstract: Methods for inducing mobilization of peripheral blood precursor cells, for elevating levels of peripheral blood precursor cells and facilitating hematopoietic reconstitution in a mammal are disclosed, comprising administering to the mammal an effective amount of an underivatized, aqueous soluble .beta.(1,3)-glucan in a triple helix conformation, which does not stimulate or prime the production of proinflammatory cytokines in vitro.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: September 12, 2000
    Assignee: The Collaborative Group, Ltd.
    Inventors: Myra L. Patchen, Paul Bleicher